Showing results (391-400 of 3,067) with videos related to
Sort By:
Pageof 307
Current Urology Reports|October 8, 2014
2013-2014 updates in Peyronie's disease managementBenjamin A Sherer, Krishnan Warrior, Laurence A LevineInternational Journal of Impotence Research|August 19, 2018
Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's diseasePeter N Tsambarlis, Raymond Yong, Laurence A LevineCurrent Diabetes Reports|June 10, 2017
SGLT2-I in the Hospital Setting: Diabetic Ketoacidosis and Other Benefits and ConcernsJoshua A Levine, Susan L Karam, Grazia AleppoSurgery, Gynecology & Obstetrics|February 1, 1979
Complications in colonoscopyW H Schwesinger, B A Levine, R RamosBrain Research|August 21, 2007
Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesityColleen M Novak, Minzhi Zhang, James A LevineJournal of Colloid and Interface Science|August 17, 2010
Electrophoresis of neutral oil in waterVolker Knecht, Zachary A Levine, P Thomas VernierJournal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|September 28, 2010
SH3BP2 mutations potentiate osteoclastogenesis via PLCγSteven A Lietman, Lihong Yin, Michael A LevineThe American Surgeon|March 5, 1998
Preoperative chemotherapy for locally advanced breast carcinoma at Charity Hospital, New Orleans, LouisianaR D Cummiskey, R Mera, E A LevineJournal of the American Academy of Audiology|March 11, 1998
Utility of EMLA in the relief of pain associated with electroneurographyA Levine, L C Cox, C B MacDonaldMolecular Endocrinology (Baltimore, Md.)|September 9, 2006
Identification of signaling molecules mediating corticotropin-releasing hormone-R1alpha-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activationAnu Punn, Michael A Levine, Dimitris K GrammatopoulosPageof 307